NPPA and cardiac hypertrophy: Atrial natriuretic peptide (ANP), an established hypertrophy marker, was upregulated in the cardiac ventricular tissues and plasma of Prdm16CKO versus controls (Fig 2E and 2F), confirming the involvement of a loss in Prdm16 in cardiac hypertrophy.